Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation and Kidney Transplantation in the Treatment of Schimke Immuno-osseous Dysplasia
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Anti-CD7 chimeric antigen receptor T cell therapy-Yake Biotechnology (Primary)
- Indications Spondyloepiphyseal dysplasia congenita
- Focus Adverse reactions
- 16 Jan 2025 New trial record